Growth hormone post-marketing surveillance: safety, sales, and the unfinished task ahead

J Clin Endocrinol Metab. 2010 Jan;95(1):52-5. doi: 10.1210/jc.2009-2364.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Comorbidity
  • Dose-Response Relationship, Drug
  • Growth Disorders / drug therapy
  • Growth Disorders / epidemiology
  • Human Growth Hormone / administration & dosage
  • Human Growth Hormone / adverse effects*
  • Human Growth Hormone / economics*
  • Human Growth Hormone / therapeutic use*
  • Humans
  • Neoplasms / chemically induced
  • Neoplasms / etiology
  • Product Surveillance, Postmarketing / trends*
  • Risk Factors

Substances

  • Human Growth Hormone